5 studies found for: Open Studies | Lymphoma OR CLL | BAY 80-6946
Japanese Phase Ib/II Copanlisib in Relapsed, Indolent B-cell NHL
Copanlisib and Rituximab in Relapsed Indolent B-cell Non-Hodgkin's Lymphoma (iNHL)
|3||Not yet recruiting||
Copanlisib and Gemcitabine in Relapsed/Refractory PTCL
Study of Copanlisib in Combination With Standard Immunochemotherapy in Relapsed Indolent Non-Hodgkin's Lymphoma (iNHL)
Phase III Copanlisib in Rituximab-refractory iNHL
† Study has passed its completion date and status has not been verified in more than two years.